Biotalys NV 2023 AR2
The report highlights Biotalys' progress in 2023, including the transition to its second-generation AGROBODY 2.0 technology platform to develop protein-based biocontrols with increased potency and lower production costs. The company appointed Kevin Helash as its new CEO and Douglas Minder as CFO to lead its next growth phase. Biotalys entered a strategic partnership with Syngenta Crop Protection to collaborate on a new bio-insecticide and continued to advance its lead biofungicide candidate, EVOCA, through regulatory processes in the US and EU. Additionally, the company successfully raised EUR 7 million through a private placement of new shares to support its pipeline development and market calibration.
Company: Biotalys NV
Sector: Professional & technical services
Country: Belgium
Year: 2023
Type: AR2
Pages: 116
Back to company
Biotalys NV
Annual Report
The report highlights Biotalys' progress in 2023, including the transition to its second-generation AGROBODY 2.0 technology platform to develop protein-based biocontrols with increased potency and lower production costs. The company appointed Kevin Helash as its new CEO and Douglas Minder as CFO to lead its next growth phase. Biotalys entered a strategic partnership with Syngenta Crop Protection to collaborate on a new bio-insecticide and continued to advance its lead biofungicide candidate, EVOCA, through regulatory processes in the US and EU. Additionally, the company successfully raised EUR 7 million through a private placement of new shares to support its pipeline development and market calibration.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Mar 14, 2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees